Boc-L-Alanine benzyl ester

Boc-L-Alanine benzyl ester is a protected L-alanine derivative commonly used as an amino acid building block in peptide synthesis workflows. The N-terminus is protected with a Boc (tert-butoxycarbonyl) group, while the carboxyl functionality is masked as a benzyl ester, providing a stable, non-zwitterionic intermediate for controlled coupling and downstream deprotection strategies. This reagent is typically selected when segment condensation or solution-phase assembly requires orthogonal control of the amino and carboxyl protecting groups.

1. Solution-Phase Peptide Synthesis

Boc-L-Alanine benzyl ester is frequently used in solution-phase peptide synthesis where Boc-protected amino acid units enable stepwise formation of peptide bonds under controlled deprotection conditions. Peptide chemists and custom peptide manufacturing groups rely on this type of protected alanine building block to assemble short to medium-length peptide segments, particularly when a benzyl ester carboxyl protection strategy is compatible with the rest of the protecting-group scheme used for the target sequence. The L-configuration supports incorporation of alanine stereochemistry into peptide products, and the dual protection pattern helps maintain the amino acid functionality during coupling and purification steps.

2. Segment Condensation Building Block

Boc-L-Alanine benzyl ester is well aligned with segment condensation approaches used to prepare peptide fragments prior to final assembly. In this workflow, protected amino acid derivatives serve as reliable coupling partners for constructing peptide segments while preserving orthogonality between N- and C-terminal functionalities across the intermediate library. Researchers developing peptide libraries for structure-activity relationship studies or mapping studies often choose benzyl ester-protected alanine units to manage carboxyl activation and to coordinate deprotection timing with other protecting groups present on the fragment. This makes the reagent a practical choice for preparing alanine-containing fragments that can be carried through iterative coupling and purification.

3. Pharmaceutical Intermediate Development

Boc-L-Alanine benzyl ester is also used as a pharmaceutical intermediate building block in industrial and medicinal chemistry settings where alanine-containing protected fragments are required for downstream synthesis of peptidomimetic scaffolds, peptide-like intermediates, or related small-molecule precursors. Process chemists value the protected, isolable form because it limits undesired side reactions from free amine or carboxylic acid groups during multi-step synthesis. The Boc/benzyl ester protection pattern supports controlled functional-group unmasking during later stages of intermediate elaboration, making it a common input material for developing alanine-derived intermediates that feed into larger synthetic sequences.

4. Analytical Reference for Protected Alanine

Boc-L-Alanine benzyl ester can be used as a reference material in analytical method development and reaction monitoring for protected amino acid chemistry, including verification of protected-group integrity during peptide-coupling sequences. Analytical chemists and peptide process development teams often require authentic protected alanine standards to confirm identity and to track consumption or formation of specific intermediates by LC-MS or HPLC workflows. The defined protection pattern (Boc on nitrogen and benzyl ester on the carboxyl) provides a characteristic profile that helps distinguish this intermediate from deprotected alanine forms or alternative ester/amide derivatives encountered during process optimization.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors